4 ms·
This was my question too, so thanks for doing the legwork. Wondering (in complete ignorance of this general topic) why they didn't jump straight to that approac
by caconym_ 3y ago
This was my question too, so thanks for doing the legwork. Wondering (in complete ignorance of this general topic) why they didn't jump straight to that approach, though...
edit: I guess maybe if you start with a healthy liver, the variable of whether the liver disease in question could affect the viability of transplanted cells is taken out of question? Presumably the immune response/immunosuppressant stuff is better characterized.
- jakewins 3y agoThat last paragraph is different though, it’s using stem cells to make liver cells, not using the patients liver cells directly.. I have no idea why not, but my wife does a lot of work growing different cell types from stem cells, and my understanding is that that’s still like.. they think they are making cell types a, b or c, but it’s a lot of uncertainty. What they really do is convert the stem cells into cells that express m various markers/pass various tests that the “real” cell type also express.. but it’s really hard to know that it’s actually a 1-1 match. Just yesterday she was lamenting they were making astrocyte cells, and many of the cells in the colony instead became.. something else, unclear what, maybe not even a cell type that exists in humans normally? Either way: using healthy liver cells from a healthy liver would be a way to ensure you actually really have liver cells, and not something that just sorta duck-types as one